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Abstract 
A sensitive and versatile competitive enzyme immunoassay (cEIA) has been developed for 
the quantitative detection of cocaine in complex forensic samples. Polyclonal anti-cocaine 
antibody was purified from serum and deposited onto microtiter plates. The concentration of 
the cocaine antibody adsorbed onto the plates, and the dilution of the cocaine-HRP hapten 
were both studied to achieve an optimised immunoassay. The method was successfully 
used to quantify cocaine in extracts taken from both paper currency and latent fingermarks. 
The limit of detection (LOD) of 0.162 ng mL-1 achieved with the assay compares favourably 
to that of conventional chromatography-mass spectroscopy techniques, with an appropriate 
sensitivity for the quantification of cocaine at the low concentrations present in some forensic 
samples. The cEIA was directly compared to LC-MS for the analysis of ten UK banknote 
samples. The results obtained from both techniques were statistically similar, suggesting that 
the immunoassay was unaffected by cross-reactivity with potentially interfering compounds. 
The cEIA was used also for the detection of cocaine in extracts from latent fingermarks. The 
results obtained were compared to the cocaine concentrations detected in oral fluid sampled 
from the same individual. Using the cEIA, we have shown, for the first time, that 
endogeneously excreted cocaine can be detected and quantified from a single latent 
fingermark. Additionally, it has been shown that the presence of cocaine, at similar 
concentrations, in more than one latent fingermark from the same individual can be linked 
with those concentrations found in oral fluid. These results show that detection of drugs in 
latent fingermarks could directly indicate whether an individual has consumed the drug. The 
specificity and feasibility of measuring low concentrations of cocaine in complex forensic 
samples demonstrates the effectiveness and robustness of the assay. The immunoassay 
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presents a simple and cost-effective alternative to the current mass spectrometry based 
techniques for the quantitation of cocaine at forensically significant concentrations. 
 
Keywords: Cocaine, competitive enzyme immunoassay, quantification, banknotes, 
fingermarks. 
 
Introduction 
The supply and consumption of illicit drugs such as cocaine is a growing societal problem on 
a global scale. In order to combat the effect of usage and trade, many countries implement 
laws that allow the seizure of circumstantial evidence associated with cocaine trafficking [1].  
It has been documented that a significant proportion of paper currency in general circulation 
is contaminated with cocaine [2-8]. Adherence of cocaine to the banknote can be due to 
surface contamination and entrapment of drug crystals between fibres of the note [9], while 
indirect transfer of cocaine is possible through contact with other notes or bank sorting 
machines [10]. Cocaine trading, using cash, and administration via a rolled up banknote can 
lead to direct exposure of banknotes to the crystalline drug powder [11]. It is thought that a 
concentration of cocaine on a note that is beyond that of the general circulation can be 
associated with drug use or trade and thus provide incriminating evidence [12, 13]. 
Quantitative methods which enable the differentiation between ‘drug money’ and general 
currency, that are suitable for daily analysis in a forensic laboratory are crucial in providing 
such evidence. It is therefore of interest that a greater range of suitable methods for this type 
of analysis be developed.  
Interest has also grown in recent years in gaining information from latent fingermarks beyond 
suspect identification. Additional information in a forensic context, such as the use by or 
recent exposure of an individual to illicit drugs, could provide enhanced evidence between a 
fingermark and a suspect.  The successful detection of cocaine and other drug compounds 
in latent fingermarks is known using a number of different analytical approaches, and is 
particularly well-described for prints artificially doped with the compound of interest [14-17]. 
However, recent advances by our research group using an immuno-labelling approach 
based on the use of fluorescently labelled, antibody-functionalised magnetic particles have 
shown the detection of drug metabolites endogenously produced in the latent fingermarks of 
drug users [18-20]. In addition, Rowell et al. were able to show isolated patches of cocaine 
contamination in a fingerprint obtained from an individual being treated at a drug addiction 
centre using surface assisted laser desorption/ionisation time-of-flight mass spectrometry 
(SALDI-TOF-MS). The non-homogenous pattern of cocaine contamination in the print was 
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thought to be due to the subject’s fingertip coming into contact with the drug prior to the time 
of sampling [16]. Analytical methods for the detection of these types of cocaine residues in 
latent fingermarks could be used in a forensic context, as their presence would provide 
further evidence of a suspect’s involvement in drug use or trade. 
 
At present, gas chromatography, liquid chromatography or thermal desorption coupled with 
mass spectrometry (MS) are most often employed for the detection of cocaine extracted 
from banknotes [4, 5, 8, 11, 21]. Alternative methods include ion-mobility spectrometry [7, 
22], electrochemiluminescence [23], and Raman microspectroscopy [9]. The 
immunodetection of cocaine on banknotes is limited to the application of strip-based 
immunoassays originally developed for qualitative detection of the drug in urine [24, 25]. The 
detection of cocaine extracted from doped fingerprints is similarly focused on MS-based 
approaches, such as desorption electrospray ionization (DESI)-MS [15] and SALDI-TOF-MS 
[16] or Raman spectroscopy [14, 17].  
 
Immunoassays such as competitive enzyme immunoassays (cEIAs), where free analyte 
from a sample competes with a labelled analyte for available antibody binding sites on a 
micro-titer plate, are also commonly used for the detection of illicit compounds in biological 
samples such as blood and urine [26]. Assays of this nature offer excellent sensitivity and 
specificity in a simple to use and cost effective manner making them highly suited for 
forensic analysis, without requiring specialised chemicals or advanced instrumentation.  
 
The aim of the present study was to develop a sensitive cEIA specifically designed for the 
quantitation of cocaine in forensic samples such as latent fingermarks and paper currency. 
Ten Bank of Scotland (UK) banknotes obtained from general circulation were tested for 
cocaine using the developed cEIA method as a preliminary indication of efficacy. The assay 
was validated by comparison with analysis of the same extracted samples by LC-MS. 
Further, the cEIA was used for the detection of cocaine in ten latent fingermarks. The 
fingermarks were obtained from five test subjects being treated for the habitual use of drugs, 
including cocaine, at a Methadone Treatment Clinic. The concentrations determined in the 
extracted fingermark samples were compared with the cocaine concentrations quantified by 
GC-MS in oral fluid samples collected from the same individuals.  
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Experimental 
Materials 
All reagents were of analytical grade, purchased from Sigma-Aldrich (UK) and used as 
received unless otherwise stated. Polyclonal anti-cocaine antibody was obtained in 1 mL 
units of rabbit serum from Europa Bioproducts (UK) and purified as reported below. ‘Slide-A-
Lyzer’ mini dialysis units (10,000 MWCO), ‘NAb Protein A plus’ spin columns, Coomassie 
brilliant blue R250, bromophenol blue sodium salt, ammonium persulfate, 96-well Nunc C8 
Maxisorp microtiter plates and 3,3',5,5' tetramethylbenzidine (TMB) substrate solution, 
50 mL centrifuge tubes and 1.5 mL Eppendorf microcentrifuge tubes were all purchased 
from Thermo Scientific (UK). Novex Sharp unstained protein standard was purchased from 
Invitrogen (UK), and N,N,N’-tetramethylethylenediamine (TEMED) was purchased from Bio 
Rad (UK). Cocaine standard (Cerilliant; 1 mg mL-1 in acetonitrile) and cocaine-horseradish 
peroxidase conjugates (cocaine-HRP) were purchased from LGC Standards (UK) and 
Randox (UK), respectively. Ten Scottish banknotes of £10 and £20 denominations from 
general circulation were kindly provided by the Scottish Crime and Drug Enforcement 
Agency (SCDEA). Ten fingermark samples on glass microscope slides were obtained from 
five volunteers attending a Methadone Treatment Clinic. 
UV-VIS absorption spectra were recorded on a Hitachi U-3000 spectrophotometer. All 
centrifugation steps were performed using a Beckman Coulter Allegra X-22R centrifuge. 
Microtiter plate absorbance intensity readings were recorded using a Perkin Elmer Wallac 
Envision 2103 multilabel microplate reader. The confirmation analysis of the banknote 
extracts was performed using a Thermo LTQ Orbitrap Discovery high resolution accurate 
mass LC-MS running in full scan positive ion electrospray mode.  The orbitrap was operating 
at a mass resolution of 30,000 FWHM at m/z 400. 
 
Anti-cocaine antibody purification 
Polyclonal anti-cocaine antibody was isolated from the supplied rabbit serum samples by 
immunoprecipitation followed by Protein A chromatography. Ammonium sulfate precipitation 
was performed using standard methodology [27], prior to dialysis in mini-dialysis units for 2 h 
against 2 L of 10 mM phosphate buffer (pH 7.4; PB). Immunochromatography was 
performed using Protein A spin columns with a sample capacity of ≤ 500 µL in accordance 
with the manufacturer’s instructions. Three columns were used to accommodate the 900 µL 
of solution to be purified. Briefly, the columns were equilibrated before use by washing twice 
with 400 µL of 10 mM phosphate-buffered saline (150 mM NaCl, pH 7.2; PBS). Wash 
solutions were removed from the columns by centrifugation for 1 min at 4,000 xg. The 
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solution containing the antibody was added at 300 µL per column, and the columns 
incubated at room temperature on a rotary mixer for 10 min. The columns were then washed 
three times with 400 µL of 10 mM PBS (pH 7.2). The antibody was eluted from the columns 
using three 400 µL additions of 0.1 M glycine (pH 2.0). Each of the resulting three fractions 
was neutralised with 40 µL of 1.0 M tris-HCL buffer (pH 8.5). The presence of antibody in the 
first and second fractions was determined by UV-VIS spectrophotometry at A280 and 
confirmed by SDS-PAGE [28]. The two fractions were combined and dialysed in mini-dialysis 
units for 2 h against 2 L of 10 mM PB (pH 7.4), and the solutions stored at -20 °C. 
 
Banknote extraction 
Extracts from the banknotes were obtained using a modified version of the method 
described by Esteve-Turrillas et al. [3]. Each banknote was rolled and placed in a 20 mL 
glass test tube with 15 mL of methanol. The tube was sealed and vortex-mixed for 5 min. 
The banknote was then removed from the tube and rinsed with a further 5 mL of methanol. 
The two extract volumes (15 and 5 mL) were combined to make up the 20 mL final volume. 
The solvent was evaporated under reduced pressure at 40 °C and the extract reconstituted 
in 0.5 mL of methanol. The reconstituted extract was centrifuged at 14,000 rpm and 4 °C for 
7 min to remove any solids while the supernatant was retained. Each extract was then 
divided into two halves; one half for cEIA and the other half for confirmation analysis by LC-
MS. Extract portions set aside for LC-MS confirmation were kept in methanol and stored at 
4 °C. For the immunoassay, 50 µL of the extract was taken and the solvent was removed by 
drying under a gentle stream of argon. The extracts were then reconstituted in 50 µL of 
10 mM PB (pH 7.4) containing 2 % v/v methanol and stored at 4 °C overnight until analysed.  
 
Fingermark extraction 
Fingermarks were obtained from volunteers known to be taking illicit drugs. Each fingermark 
was deposited onto a clean glass microscope slide. The fingermarks were provided by the 
volunteers with no pre-treatment, i.e., the fingermarks contained a mixture of sebum and 
eccrine sweat. Oral fluid samples were collected from the volunteers at the same time and 
analysed by GC-MS. Fingermarks from drug-free volunteers were taken in the same manner 
as for the test subjects and used as negative controls. Full ethical permission was obtained 
prior to collection of samples. Cocaine was extracted from each fingermark separately using 
a similar method as described previously for the banknote samples. Specifically, the 
microscope slide with the fingermark was inserted into a 50 mL centrifuge tube, and 20 mL 
of methanol was added. The tube was sealed and vortex-mixed for 5 min. The solvent was 
evaporated under reduced pressure at 40 °C and the extract reconstituted in 0.5 mL of 
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10 mM PB (pH 7.4) containing 2 % v/v methanol. The samples were stored at 4 °C overnight 
until analysed.   
 
Preparation of standard and sample solutions 
A cocaine standard stock solution (1 mg mL-1) was prepared in advance of analysis as 
follows. A 50 µL aliquot of cocaine standard was taken and the acetonitrile removed by 
evaporation under a gentle stream of argon. The standard was then reconstituted in 50 µL of 
10 mM PB (pH 7.4) containing 2 % v/v acetonitrile. A standard curve was prepared on the 
day of analysis by diluting the stock solution to known concentrations in 10 mM PB (pH 7.4). 
The concentrations of cocaine for each curve were as follows; 0.78, 1.56, 3.125, 6.25, 12.5, 
25, 50 and 100 ng mL-1 for the analysis of banknote extracts, and 0.195, 0.39, 0.78, 1.56, 
3.125, 6.25, 12.5, and 25 ng mL-1 for the analysis of fingermark extracts. Banknote extracts 
were diluted to 1:500 by adding 1 µL of sample to 499 µL of 10 mM PB (pH 7.4), or to 1:1000 
by adding 1 µL of sample to 999 µL of PB immediately prior to analysis. Fingermark extracts 
were not diluted prior to analysis.  
 
Anti-cocaine competitive enzyme immunoassay (cEIA) 
A schematic overview of the developed cEIA method is shown in Fig. 1. The assay involved 
the adsorption of the purified anti-cocaine antibody (1 µg mL-1) to a microtiter plate at 100 µL 
per well. During initial development, a comparison between 10 mM PB (pH 7.4) and 100 mM 
carbonate buffer (pH 9.5) showed greater adsorption of antibody occurred when the 
carbonate buffer was used as a diluent. Therefore, adsorption using antibody diluted in 
carbonate buffer was used thereafter. The plate containing the antibody (1 µg mL-1 in 
carbonate buffer) was incubated overnight (18 h) at 4 °C and then washed three times with 
10 mM PBS containing  0.05 % v/v Tween-20 (100 mM NaCl, pH 7.4; PBS/T). Blocking 
buffer, PBS containing 1 % w/v bovine serum albumin (PBS/BSA), was added at 200 µL per 
well and incubated at room temperature for 2 h. The plate was then washed a further three 
times with PBS/T before the addition of pre-diluted standards and extracted samples (in PB) 
at 50 µL per well. Following the addition of sample and standard solutions the plate was 
incubated for 2 h at room temperature. After incubation, 50 µL of the cocaine-HRP 
conjugate, at varying dilutions in blocking buffer containing 0.05 % v/v Tween-20, was added 
to each well. The solutions were mixed by gently tapping the side of the plate several times 
and then incubated for 2 h at room temperature. The plate was then washed four times with 
PBS/T. TMB substrate solution was added at 100 µL per well followed by a 20 min 
incubation at room temperature in the absence of light. Sulfuric acid (0.5 M) was added at 
100 µL/well to stop the enzymatic reaction, after which the absorbance of each well was 
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measured at A450 using the multi-label micro-plate reader. Wells without antibody were used 
as a blank. The intensity of the absorbance measured was inversely proportional to the 
quantity of cocaine in the extracted sample.  
Absorbance intensities were corrected for cocaine-HRP binding without the presence of 
cocaine by dividing the signal of the sample or standard solution (B) by that of the zero 
concentration calibrator (B0). The standard curve was generated by plotting the cocaine 
concentration (on a logarithmic scale) against the logit of the corrected absorbance intensity 
(Logit (B/B0)). For this the overall formula Logit (B/B0) = [In ((B/B0)/(1-(B/B0)))] was applied 
[29].  
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Fig. 1 A schematic representation of the cEIA for the detection of cocaine in extracted 
samples from banknotes or latent fingermarks.  
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Results and discussion 
 
cEIA calibration, detection limit and precision 
Typical calibration curves for cocaine using the cEIA are shown in Fig. 2A and 2B. These 
curves were generated using cocaine standard in a buffer solution at concentrations ranging 
from 0.78 to 100.00 ng mL-1, and 0.195 to 25.00 ng mL-1 for the analysis of banknote and 
fingermark extracts, respectively. The data showed a good correlation coefficient (r2 = 0.999) 
on the logit-log plot using a linear regression for both calibration curves (Fig. 2C and 2D). 
The detection limit of the cEIA was calculated from the average absorbance values from six 
replicate analyses of the blank minus three times the standard deviation of the average. The 
resulting absorbance value was then extrapolated from the log-logit standard curve. The 
minimum detectable concentration of cocaine was determined as 0.162 ng mL-1. This 
detection limit compares favourably to the 0.95 ng mL-1 limit reported for the detection of 
cocaine and metabolites in oral fluid using a commercial micro-plate EIA [30], and to the 
1.0 ng mL-1 achieved using GC-MS with solid phase extraction for the detection of cocaine 
on banknote samples [6].  
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Fig. 2 Typical standard curves showing the corrected absorbance response (B/B0) as a 
function of cocaine concentration in the range of: (A) 0.78 to 100.00 ng mL-1 for banknote 
analysis; and (B) 0.195 to 25.00 ng mL-1 for fingermark analysis. Each point represents the 
mean ± SD of at least three measurements. The corresponding logit-log linear calibration 
curves are shown for banknote and fingermark analysis in (C) and (D), respectively. 
 
The precision of the assay was estimated based on repeat measurements of standard 
cocaine samples prepared in assay buffer (10 mM PB, pH 7.4). Standards at three different 
cocaine concentrations (6.25, 25 and 100 ng mL-1) were used. The intra-assay precision was 
determined using four replicates of each standard in a single analysis (n = 4). Inter-assay 
precision was similarly assessed by analysing the same sample, as four repetitions, across 
three separate analyses undertaken on different days over a period of 30 days (n = 12). The 
results presented in Table 1 highlights the precision of the developed cEIA for the 
quantitative detection of cocaine, with confidence variables of 1.58-6.54 % and 4.38-6.69 % 
for intra- and inter-assay precision, respectively. 
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Table 1 Precision of the cEIA for the quantification of cocaine. 
Cocaine (ng mL-1) 
Intra-assay (n = 4)  Inter-assay (n = 12) 
Mean ± SD 
(ng mL-1) CVa (%) 
 Mean ± SD  
(ng mL-1) CVa (%) 
6.25 6.100 ± 0.097 1.58  6.363 ± 0.279 4.38 
25.0 25.119 ± 0.894 3.56  25.849 ± 1.207 4.67 
100.0 98.723 ± 6.456 6.54  98.416 ± 6.587 6.69 
aCV is the coefficient of variation. 
 
 
Evaluation of cEIA performance with real banknote samples  
 
UK banknotes comprise cotton and linen paper [12]. The way in which paper currency is 
handled and transferred means that a number of contaminants for example; dust, soil, food 
particles and cosmetics, can all be found on the fibres of a banknote. At a trace level, 
predominantly caffeine, nicotine, paracetamol and other pharmaceutical compounds have 
been reported on banknotes [10]. Drugs such as cocaine and its metabolite 
benzoylecgonine, tetrahydrocannabinol (THC), heroin, amphetamines, and ketamine have 
also been detected [1].  
 
Typically, cocaine is extracted from banknotes using an organic solvent. For 
chromatographic analyses, this is followed by a form of sample clean-up such as 
centrifugation or filtration [13]. Such steps can be avoided with immunochemical analysis 
simply by diluting the sample in buffer prior to analysis [31]. Optimising immunoassays for 
pre-diluted samples lessens possible matrix effects by reducing the overall concentration of 
potential interferents in the sample, while maintaining an analyte concentration that is within 
the working range of the assay.  
 
As highlighted, extracts from banknotes could contain a number of potential immunoassay 
interferents. Consequently, the influence of the chemical ‘matrix effect’ on the cEIA was 
determined. The general practise to test matrix effects involves spiking blank sample 
matrices with an appropriate standard at a known concentration and thus determining the 
accuracy of the assay results. As the majority of banknotes in general circulation are 
reported to be contaminated with cocaine such notes could not be used for spiking. 
Previously uncirculated banknotes were also avoided as they lack the appropriate ‘handling 
and transfer’ contaminants to properly represent the sample matrix. Instead, cocaine was 
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extracted from ten UK banknote samples using a modified version of the method described 
by Esteve-Turrillas et al. [3]. Esteve-Turrillas et al. reported recoveries of 101 ± 2 and 98 ± 
3 % in spiked banknote samples extracted using their method followed by GC-MS-MS 
analysis.  
 
The extracts from the banknote samples were each subjected to two dilution factors (1:500 
and 1:1000) and analysed by the cEIA. The cocaine concentrations were corrected for the 
dilution factor and compared to determine what effect doubling the optimised concentration 
of raw extract would have on the accuracy of the assay. Results showing the change in 
absorbance relative to cocaine concentration in standard solutions and the absorbance 
response to the two extract concentrations are shown in Fig. 3A and 3B, respectively. The 
values shown in Fig. 3A were used to generate the standard curve from which the cocaine 
concentrations obtained from the ten banknote samples were calculated (Fig. 3B and Table 
2). The average difference in cocaine concentration between the two extract dilutions across 
all of the ten banknote samples was ± 0.810 µg mL-1. The differences ranged from ± 0.037 to 
1.915 µg mL-1. The variation in concentration between the two sample dilutions showed that 
the matrix does affect the response of the assay, although the variation between the two 
dilutions did not exceed the standard deviation obtained from the repeat measurements 
(results not shown). An overall increase in the absorbance signal was obtained using the 
more dilute (1:1000) rather than the more concentrated (1:500) samples, suggesting that the 
1:1000 dilution provides a more appropriate matrix for the cEIA. Based on this, the 
quantitative results obtained using the 1:1000 sample dilution were applied to the parallel 
analysis using LC-MS.  
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Fig. 3 The absorbance intensity obtained (A) using the cEIA from a series of cocaine 
standard solutions, and (B) from ten extracted banknote samples. The ten banknote samples 
were diluted to a factor of 1:1000 and 1:500. The results from the two dilutions of each 
banknote sample are shown in the order of lowest extract concentration to highest. As an 
example, the 1:1000 and 1:500 dilutions of Sample 10 are labelled (*) and (**), respectively. 
Each absorbance value represents the mean ± SD of at least four measurements. 
 
The results obtained from the cEIA for the banknote extracts were compared with those 
obtained by a conventional LC-MS method. Extracts from the ten UK banknote samples 
were obtained as described and analysed using the two techniques using the same cocaine 
standard as a reference. The LC-MS analysis was performed using the method described by 
Hudson and Timber [32]. Table 2 shows the concentration values obtained using the cEIA 
and LC-MS. Using a paired t-test it was shown that the concentrations determined using the 
two techniques did not differ significantly from one another at P = 0.1. Benzoylecgonine 
(BE), a major metabolite of cocaine, and other compounds of structural similarity were 
detected by the LC-MS in the extracted samples (results not shown). Despite the presence 
of these potential interferents, the cEIA yielded cocaine concentrations similar to those 
detected by LC-MS. The agreement between the results of the immunoassay and the LC-
MS analysis suggests that the assay was not affected by cross-reactivity when applied to the 
analysis of cocaine in real banknote samples. The results show that the developed cEIA 
therefore enables the quantitation of cocaine in complex banknote extracts with a degree of 
sensitivity that is comparable to the current chromatographic-mass spectrometry technique. 
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Table 2 Results of a quantitative analysis of cocaine extracted from ten UK banknote 
samples undertaken using the cEIAa and LC-MS. 
Sample 
cEIA, 
µg mL-1 
LC-MS, 
µg mL-1 
1 9.322   ± 1.655  4.181 
2 7.317   ± 4.233 10.026 
3 19.131 ± 1.031 13.044 
4 6.921   ± 0.553  4.699 
5 0.385   ± 0.025  0.448 
6 0.297   ± 0.143  0.245 
7 11.945 ± 1.320  8.583 
8 0.467   ± 0.107  0.529 
9 19.950 ± 1.567 13.780 
10 1.893   ± 0.177  2.205 
aEach cEIA value represents the mean ± SD of at least three measurements. 
 
Application of the cEIA for the analysis of latent fingermarks 
 
Two possibilities exist for the way in which latent fingermarks can become contaminated with 
cocaine. The first of these is through contact transfer, known to occur when the fingertip of 
an individual comes into contact with the crystalline drug powder. The crystals of cocaine 
stick to the sweaty skin of the fingertip for a short time, and via the sweat are transferred to 
surfaces that the skin comes into contact with. The second route for contamination of 
fingermarks is as a result of the individual taking the drug itself. When a drug enters the body 
it is transported via the circulation to the liver, where it is metabolised, transported to the 
kidneys and then excreted in the urine. During this process, drugs and drug metabolites can 
be secreted onto the skin surface from the circulation through the action of sweating [33]. 
Hazarika et al. have shown that drug metabolites such as benzoylecgonine, a major 
metabolite of cocaine, were present at a detectable level in the fingermarks of cocaine users 
[18, 19]. In addition, the use of SALDI-TOF-MS enabled the detection of EDDP, a major 
metabolite of methadone, together with its parent drug in the same fingermark from an 
individual taking methadone [16]. As methadone is taken as an oral dose, it was concluded 
that the presence of the parent drug in the fingermark arises from its secretion from the 
blood in the same manner as for metabolites. The presence and quantitation of cocaine at a 
detectable level in the sweat of a fingermark from a known cocaine user has not previously 
been reported. 
 
Several studies have shown a strong correlation between cocaine concentration in oral fluid 
and in plasma, proving oral fluid to be an appropriate sample matrix for the detection of drug 
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use [34, 35]. Due to its rapid elimination, with a half-life of only 3 h, the detection of cocaine 
in oral fluid is a suitable indicator of recent drug use close to the time of sampling [36]. In this 
study, oral fluid and latent fingermark samples were taken at the same time from five 
individuals attending a Methadone Treatment Clinic. Two fingermark samples were taken 
per subject and extracted and analysed using the developed cEIA method. The results were 
compared with the results of GC-MS analysis of the corresponding oral fluid samples. 
 
The concentrations of cocaine determined in the oral fluid samples by GC-MS, and the 
extracted fingermarks by cEIA are shown in Fig 4 (A) and (B), respectively. Cocaine was 
detected in oral fluid samples from three of the five test subjects, with the sample from 
subject P2 containing the highest concentration (19 ng mL-1). This corresponds to the 
highest concentration of cocaine determined using the cEIA in both fingermarks from subject 
P2 at 0.728 and 0.879 ng mL-1 for (a) and (b) samples, respectively. The oral fluid samples 
from subjects P1 and P3 also tested positive for cocaine. These positive cocaine tests 
correspond to positive fingermark samples, although the relative concentrations are different. 
The fingermarks from subject P4 gave cocaine results where one print was significantly 
higher than the other print. Since the oral fluid result from volunteer P4 was negative, 
contamination by contact transfer could possibly account for this result. The fingermark 
samples P4(a), both prints from P5 and the negative control samples (P6 and P7) did not 
contain cocaine at detectable concentrations based on the sensitivity of the assay. 
 
The overall trend of the data shows that the cocaine present in the latent fingermark samples 
as determined by the cEIA reflects that of the oral fluid concentrations, particularly as the 
concentrations detected were similar in both of the fingermark samples from the same 
subject. The developed cEIA method proved to be readily applicable for the analysis of these 
types of samples, even at cocaine concentrations within the fingermark extract of less than 
1 ng mL-1.  As the presence of the drug in oral fluid is a recognised indicator of recent 
cocaine use, the results obtained suggest, for the first time, that the detection of cocaine in 
the sweat of a latent fingermark could be similarly linked to consumption.   
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Fig. 4 (A) Results of a quantitative analysis of cocaine by GC-MS on oral fluid samples 
taken from five individuals (numbered P1 – P5) from a methadone maintenance clinic, and 
(B) results of the cEIA analysis of cocaine extracted from fingermarks of individuals P1-P5, 
taking two fingermarks (samples a and b) from each individual. The first ten fingermarks, P1-
P5, correspond to the individuals from which oral fluid was also taken. P6 and P7 were 
single prints obtained from two separate drug-free individuals as negative controls. Each 
concentration value represents the mean ± SD of at least three measurements. 
 
 
Conclusions 
 
In this study, a non-destructive and sensitive competitive enzyme immunoassay (cEIA) 
enabling the quantitation of cocaine in complex forensic samples such as extracts from 
banknotes and latent fingermarks has been developed. The level of sensitivity achieved by 
the assay, with a LOD of 0.162 ng mL-1, enables the quantitation of cocaine in samples of 
forensic significance. The quantification of cocaine from ten UK banknote samples was 
performed using the cEIA and compared by parallel LC-MS analysis. The results from both 
methods were found to be in agreement, indicating that the cEIA has the required specificity 
for the analysis of complex, heavily contaminated banknote extracts, and is not affected by 
the presence of BE and other potential interferents in the samples. Trace levels of cocaine 
were detected from all ten banknotes sampled using the assay. The concentrations detected 
were in agreement with the background levels of cocaine detected on Irish Euro banknotes 
in general circulation [5].  
The cEIA was similarly applied to the quantification of cocaine extracted from latent 
fingermarks donated by five individuals attending a Methadone Treatment Clinic. The results 
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were compared to the cocaine concentrations determined by GC-MS in oral fluid samples 
obtained from the test subjects at the time the fingermarks were taken. The overall trend of 
the data showed, for the first time, that the cocaine detected at similar concentrations in 
more than one latent fingermark from the same individual followed the same pattern as 
those in oral fluid. The results suggest that the detection of drugs from fingermarks could be 
associated with consumption. The developed cEIA offers a straight forward, cost-effective 
alternative to chromatography-MS techniques for the quantitation of cocaine in forensic 
samples, without the need for specialised instrumentation. The simplicity of the developed 
cEIA provides a method that would be readily applicable for everyday analysis in a forensic 
laboratory. 
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